Nephros, Inc. (USD) Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.

Nephros, Inc. (USD) Active

380 Lackawanna Place, South Orange, NJ, US, 07079

Stock Price USD

Price Change

Last Dividend USD

Latest Rating

NEPH's stock peer is BEAT (HeartBeam, Inc.)

NEPH's stock peer is DXR (Daxor Corporation)

NEPH's stock peer is HOWL (Werewolf Therapeutics, Inc.)

NEPH's stock peer is ICCC (ImmuCell Corporation)

NEPH's stock peer is NRXP (NRx Pharmaceuticals, Inc.)

NEPH's stock peer is ONMD (OneMedNet Corporation)

NEPH's stock peer is OSTX (OS Therapies Incorporated)

NEPH's stock peer is OTLK (Outlook Therapeutics, Inc.)

NEPH's stock peer is SPRB (Spruce Biosciences, Inc.)

NEPH's stock peer is ZJYL (Jin Medical International Ltd.)

Healthcare Medical - Instruments & Supplies

Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.

20%

Dcf Rating

80%

Return On Equity

100%

Return On Assets

60%

Debt To Equity

20%

Price To Earnings

40%

Price To Book

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Recent News

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”

SOUTH ORANGE, N.J., June 18, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will host a virtual investor event titled, “Beyond Filtration: The Nephros Model in Action” on July 16th, 2026.

2026-06-18 07:04:04

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”

SOUTH ORANGE, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will host a virtual investor event titled, “Beyond Filtration: The Nephros Model in Action” on July 16th, 2026.

2026-06-18 07:00:00

Nephros Announces Financial Results for Quarter Ended March 31, 2026

SOUTH ORANGE, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2026.

2026-05-07 16:05:00

�Nephros Schedules First Quarter 2026 Financial Results Conference Call

SOUTH ORANGE, NJ, April 30, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.

2026-04-30 16:15:08

Nephros Schedules First Quarter 2026 Financial Results Conference Call

SOUTH ORANGE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Thursday, May 07, 2026 after market close and will host a conference call that same day at 4:30pm ET.

2026-04-30 16:00:00

Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership

Company targets one of the largest and most complex water safety markets in the U.S. to accelerate growth. SOUTH ORANGE, NJ, April 16, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.

2026-04-16 10:05:35

Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership

SOUTH ORANGE, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced an expansion of its strategic focus in the Greater New York City region with the addition of Dana Cunningham as a dedicated regional sales leader.

2026-04-16 09:57:00

�Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

New capability adds consultative support and strengthens Nephros' broader water safety offering SOUTH ORANGE, NJ, April 1, 2026 PRISM MediaWire (Press Release Service – Press Release Distribution)– Nephros, Inc.

2026-04-01 09:01:20

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise

SOUTH ORANGE, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced an expansion of its customer-facing, water-safety support capabilities following the ASSE 12080 Legionella Water Safety and Management Specialist Certification earned by Brianne McGuire, Director of Business Development.

2026-04-01 09:00:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions